Literature DB >> 7743677

The influence of allo-class II MHC-specific Th2 cells on the generation of CD4 and CD8 cytotoxic T cells to associated class I and class II MHC alloantigen.

P J Wood1, I A Cossens.   

Abstract

There is considerable interest in whether CD4 T cell function can affect the outcome of allogeneic transplants. In mice tolerant to an isolated class II MHC disparity, the normal Th1 activity in vitro associated with graft rejection is switched to Th2 in tolerant animals. Because clinical transplants involve multiple class I and II MHC disparities we tested how the switch to Th2 activity of tolerant mice would affect the generation of CD4 and CD8 cytotoxic T cells (CTL) against MHC alloantigens to which the mice were not tolerant. A.TH mice (KkIsDd) were rendered neonatally tolerant of A.TL (KkIkDd) and the generation of CD4 or CD8 CTL measured in a mixed lymphocyte reaction (MLR) against (A.TL x B6)F1 stimulators. Normal mice generated CD4 CTL against both A.TL and B6 (KbIbDb), but tolerant mice were unable to generate cytotoxicity against either A.TL or B6. However, tolerant cells were able to generate CD8 CTL against B6. IL-4 inhibited the generation of CD4, but not CD8, CTL by normal cells and anti-IL-4 antibody was shown to increase the generation of CD4 CTL against B6 in F1 stimulated cultures. Overall the results showed that a Th2 response could inhibit the generation of CD4 CTL against concomitant alloantigen in a process at least partially involving IL-4, but that, conversely, tolerant Th2 cells could help in the generation of CD8 CTL. The results suggest that with whole MHC disparities a simple change of CD4 T cells to Th2 would not be enough to procure graft acceptance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743677      PMCID: PMC1534320          DOI: 10.1111/j.1365-2249.1995.tb03677.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody.

Authors:  A S Rosenberg; D S Finbloom; T G Maniero; P H Van der Meide; A Singer
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

2.  Specific assays for cytokine production by T cells.

Authors:  T R Mosmann; T A Fong
Journal:  J Immunol Methods       Date:  1989-01-17       Impact factor: 2.303

3.  In vitro suppression of cytotoxic T cell generation by lymphocytes from mice rendered neonatally tolerant of class II MHC alloantigens.

Authors:  T J Powell; J W Streilein
Journal:  Transplantation       Date:  1991-08       Impact factor: 4.939

4.  IL-10: a novel cytotoxic T cell differentiation factor.

Authors:  W F Chen; A Zlotnik
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

5.  CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells.

Authors:  P Erb; D Grogg; M Troxler; M Kennedy; M Fluri
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

Review 6.  CD4+ T cells: specificity and function.

Authors:  C A Janeway; S Carding; B Jones; J Murray; P Portoles; R Rasmussen; J Rojo; K Saizawa; J West; K Bottomly
Journal:  Immunol Rev       Date:  1988-01       Impact factor: 12.988

7.  Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.

Authors:  D W Lancki; C S Hsieh; F W Fitch
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

Review 8.  Interleukin-2: inception, impact, and implications.

Authors:  K A Smith
Journal:  Science       Date:  1988-05-27       Impact factor: 47.728

9.  Cloned L3T4+ T lymphocytes protect mice against Listeria monocytogenes by secreting IFN-gamma.

Authors:  D M Magee; E J Wing
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

10.  Expression of two distinct cytolytic mechanisms among murine CD4 subsets.

Authors:  S T Ju; N H Ruddle; P Strack; M E Dorf; R H DeKruyff
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.